Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 194

1.

Initialization and Readout of Nuclear Spins via a Negatively Charged Silicon-Vacancy Center in Diamond.

Metsch MH, Senkalla K, Tratzmiller B, Scheuer J, Kern M, Achard J, Tallaire A, Plenio MB, Siyushev P, Jelezko F.

Phys Rev Lett. 2019 May 17;122(19):190503. doi: 10.1103/PhysRevLett.122.190503.

PMID:
31144926
2.

Mimicking Electromagnetic Wave Coupling in Tokamak Plasma with Fishnet Metamaterials.

Rustomji K, Abdeddaim R, Achard J, Chmiaa M, Georget E, Goniche M, Helou W, Hillairet J, Enoch S, Tayeb G.

Sci Rep. 2018 Apr 11;8(1):5841. doi: 10.1038/s41598-018-24250-0.

3.

Angiotensin IV improves subnormothermic machine perfusion preservation of rat liver graft.

Tabka D, Bejaoui M, Javellaud J, Achard JM, Ben Abdennebi H.

Biomed Pharmacother. 2018 Aug;104:841-847. doi: 10.1016/j.biopha.2018.02.080. Epub 2018 Mar 31.

PMID:
29609847
4.

Intraprostatic Fiducials Compared with Bony Anatomy and Skin Marks for Image-Guided Radiation Therapy of Prostate Cancer.

Moreau J, Biau J, Achard JL, Toledano I, Benhaim C, Kwiatkowski F, Loos G, Lapeyre M.

Cureus. 2017 Oct 12;9(10):e1769. doi: 10.7759/cureus.1769.

5.

Reduction of Dislocations in Single Crystal Diamond by Lateral Growth over a Macroscopic Hole.

Tallaire A, Brinza O, Mille V, William L, Achard J.

Adv Mater. 2017 Apr;29(16). doi: 10.1002/adma.201604823. Epub 2017 Feb 20.

PMID:
28218441
6.

[Partial delegation to radiation therapists of the control by cone beam CT of prostate positioning].

Benhaïm C, Loos G, Achard JL, Berger L, Caillé C, Frédéric-Moreau T, Biau J, Lapeyre M.

Cancer Radiother. 2017 Feb;21(1):28-33. doi: 10.1016/j.canrad.2016.07.104. French.

PMID:
28214286
7.

[Salvage concomitant chemoradiation therapy for non-metastatic inflammatory breast cancer after chemotherapy failure].

Bellière-Calandry A, Benoît C, Dubois S, Moreau J, Achard JL, Loos G, Mouret-Reynier MA, Van Praagh-Doreau I, Gimbergues P, Lebouedec G, Pomel C, Lapeyre M.

Cancer Radiother. 2015 Dec;19(8):739-45. doi: 10.1016/j.canrad.2015.06.020. Epub 2015 Dec 1. French.

PMID:
26597412
8.

Effects of Institut Georges Lopez-1 and Celsior preservation solutions on liver graft injury.

Tabka D, Bejaoui M, Javellaud J, Roselló-Catafau J, Achard JM, Abdennebi HB.

World J Gastroenterol. 2015 Apr 14;21(14):4159-68. doi: 10.3748/wjg.v21.i14.4159.

9.

Candesartan restores pressure-induced vasodilation and prevents skin pressure ulcer formation in diabetic mice.

Danigo A, Nasser M, Bessaguet F, Javellaud J, Oudart N, Achard JM, Demiot C.

Cardiovasc Diabetol. 2015 Feb 18;14:26. doi: 10.1186/s12933-015-0185-4.

10.

Low-to-moderate Reynolds number swirling flow in an annular channel with a rotating end wall.

Davoust L, Achard JL, Drazek L.

Phys Rev E Stat Nonlin Soft Matter Phys. 2015 Feb;91(2):023019. Epub 2015 Feb 27.

PMID:
25768609
11.

Opposite effects of angiotensins receptors type 2 and type 4 on streptozotocin induced diabetes vascular alterations in mice.

Nasser M, Clere N, Botelle L, Javellaud J, Oudart N, Faure S, Achard JM.

Cardiovasc Diabetol. 2014 Feb 10;13:40. doi: 10.1186/1475-2840-13-40.

12.

Salivary glands radiotherapy to reduce sialorrhea in amyotrophic lateral sclerosis: dose and energy.

Bourry N, Guy N, Achard JL, Verrelle P, Clavelou P, Lapeyre M.

Cancer Radiother. 2013 Jun;17(3):191-5. doi: 10.1016/j.canrad.2013.01.010. Epub 2013 Mar 19.

PMID:
23517881
13.

Association between angiotensin receptor blockers and better cognitive outcome: urgent need for a randomized trial.

Oprisiu R, Fournier A, Achard JM, Black SE, Serot JM, Godefroy O.

JAMA Neurol. 2013 Mar 1;70(3):413-4. doi: 10.1001/jamaneurol.2013.1804. No abstract available.

PMID:
23478839
14.

Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20 years single institution study.

Monrigal E, Dauplat J, Gimbergues P, Le Bouedec G, Peyronie M, Achard JL, Chollet P, Mouret-Reynier MA, Nabholtz JM, Pomel C.

Eur J Surg Oncol. 2011 Oct;37(10):864-70. doi: 10.1016/j.ejso.2011.07.009. Epub 2011 Aug 16.

PMID:
21843920
15.

Erythropoietin restores C-fiber function and prevents pressure ulcer formation in diabetic mice.

Demiot C, Sarrazy V, Javellaud J, Gourloi L, Botelle L, Oudart N, Achard JM.

J Invest Dermatol. 2011 Nov;131(11):2316-22. doi: 10.1038/jid.2011.211. Epub 2011 Aug 11.

16.

WNK1 regulates vasoconstriction and blood pressure response to α 1-adrenergic stimulation in mice.

Bergaya S, Faure S, Baudrie V, Rio M, Escoubet B, Bonnin P, Henrion D, Loirand G, Achard JM, Jeunemaitre X, Hadchouel J.

Hypertension. 2011 Sep;58(3):439-45. doi: 10.1161/HYPERTENSIONAHA.111.172429. Epub 2011 Jul 18.

PMID:
21768522
17.

Long-term follow-up after laparoscopic management of endometrial cancer in the obese: a fifteen-year cohort study.

Rabischong B, Larraín D, Canis M, Le Bouëdec G, Pomel C, Jardon K, Kwiatkowski F, Bourdel N, Achard JL, Dauplat J, Mage G.

J Minim Invasive Gynecol. 2011 Sep-Oct;18(5):589-96. doi: 10.1016/j.jmig.2011.05.015. Epub 2011 Jun 29.

PMID:
21719359
18.

Fast and continuous plasma extraction from whole human blood based on expanding cell-free layer devices.

Sollier E, Cubizolles M, Fouillet Y, Achard JL.

Biomed Microdevices. 2010 Jun;12(3):485-97. doi: 10.1007/s10544-010-9405-6.

PMID:
20204703
19.

[Sexual dysfunction after curietherapy and external radiotherapy of the prostate for localized prostate cancer].

Huyghe E, Bachaud JM, Achard JL, Bossi A, Droupy S; les membres du comité d'andrologie de l'AFU.

Prog Urol. 2009 Dec;19 Suppl 4:S173-6. doi: 10.1016/S1166-7087(09)73368-8. Review. French.

PMID:
20123514
20.

A passive microfluidic device for plasma extraction from whole human blood.

Sollier E, Cubizolles M, Faivre M, Fouillet Y, Achard JL.

Conf Proc IEEE Eng Med Biol Soc. 2009;2009:7030-3. doi: 10.1109/IEMBS.2009.5333314.

PMID:
19964193
21.

Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.

Fournier A, Oprisiu-Fournier R, Serot JM, Godefroy O, Achard JM, Faure S, Mazouz H, Temmar M, Albu A, Bordet R, Hanon O, Gueyffier F, Wang J, Black S, Sato N.

Expert Rev Neurother. 2009 Sep;9(9):1413-31. doi: 10.1586/ern.09.89. Review.

PMID:
19769454
22.

Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors?

Oprisiu-Fournier R, Faure S, Mazouz H, Boutitie F, Serot JM, Achard JM, Godefroy O, Hanon O, Temmar M, Albu A, Strandgaard S, Wang J, Black SE, Fournier A.

Expert Rev Neurother. 2009 Sep;9(9):1289-305. doi: 10.1586/ern.09.88. Review.

PMID:
19769445
23.

Ultralong spin coherence time in isotopically engineered diamond.

Balasubramanian G, Neumann P, Twitchen D, Markham M, Kolesov R, Mizuochi N, Isoya J, Achard J, Beck J, Tissler J, Jacques V, Hemmer PR, Jelezko F, Wrachtrup J.

Nat Mater. 2009 May;8(5):383-7. doi: 10.1038/nmat2420. Epub 2009 Apr 6.

PMID:
19349970
24.

Telmisartan for prevention of cardiovascular events.

Fournier RO, Achard JM, Fournier A.

N Engl J Med. 2009 Jan 15;360(3):303; author reply 303. No abstract available.

PMID:
19148964
25.

Protective effect of candesartan in experimental ischemic stroke in the rat mediated by AT2 and AT4 receptors.

Faure S, Bureau A, Oudart N, Javellaud J, Fournier A, Achard JM.

J Hypertens. 2008 Oct;26(10):2008-15. doi: 10.1097/HJH.0b013e32830dd5ee.

PMID:
18806625
26.

Comparison of the prognostic significance of Chevallier and Sataloff's pathologic classifications after neoadjuvant chemotherapy of operable breast cancer.

Penault-Llorca F, Abrial C, Raoelfils I, Cayre A, Mouret-Reynier MA, Leheurteur M, Durando X, Achard JL, Gimbergues P, Chollet P.

Hum Pathol. 2008 Aug;39(8):1221-8. doi: 10.1016/j.humpath.2007.11.019. Epub 2008 Jun 10.

PMID:
18547616
27.

Capillary permeability and extracellular volume fraction in uterine cervical cancer as patient outcome predictors: measurements by using dynamic MRI spin-lattice relaxometry.

Dedieu V, Bailly C, Vincent C, Achard JL, Le Bouedec G, Penault-Llorca F, Verrelle P, Vincensini D.

J Magn Reson Imaging. 2008 Apr;27(4):846-53. doi: 10.1002/jmri.21324.

PMID:
18383262
28.

The JIKEI trial.

Boutitie F, Gueyffier F, Achard JM, Temmar M, Fournier A.

Lancet. 2007 Dec 1;370(9602):1825-6. No abstract available.

PMID:
18061051
29.

[Diuretic-based therapy].

Presne C, Monge M, Mansour J, Oprisiu R, Choukroun G, Achard JM, Fournier A.

Nephrol Ther. 2007 Oct;3(6):392-426. Epub 2007 Jul 27. Review. French.

PMID:
17919642
30.
31.

Changes in and prognostic value of hormone receptor status in a series of operable breast cancer patients treated with neoadjuvant chemotherapy.

Tacca O, Penault-Llorca F, Abrial C, Mouret-Reynier MA, Raoelfils I, Durando X, Achard JL, Gimbergues P, Curé H, Chollet P.

Oncologist. 2007 Jun;12(6):636-43.

32.

Treating stroke in the 21st century.

Oprisiu R, Serot JM, Black SE, Achard JM, Fournier A.

Lancet. 2007 Mar 31;369(9567):1080. No abstract available.

PMID:
17398303
33.

[Indications, contra-indications, expected results and choice of neoadjuvant chemotherapy for operable breast cancer].

Mouret-Reynier MA, Abrial C, Leheurteur M, Durando X, Van Praagh I, Gimbergues P, Achard JL, Ferrière JP, Cure H, Chollet P.

Bull Cancer. 2006 Nov;93(11):1121-9. Review. French.

34.

Synergistic protective effects of erythropoietin and olmesartan on ischemic stroke survival and post-stroke memory dysfunctions in the gerbil.

Faure S, Oudart N, Javellaud J, Fournier A, Warnock DG, Achard JM.

J Hypertens. 2006 Nov;24(11):2255-61.

PMID:
17053548
35.

Cerebroprotective effect of angiotensin IV in experimental ischemic stroke in the rat mediated by AT(4) receptors.

Faure S, Chapot R, Tallet D, Javellaud J, Achard JM, Oudart N.

J Physiol Pharmacol. 2006 Sep;57(3):329-42.

36.

AT1 receptor blockers for cognition decline after cardiac surgery?

Oprisiu-Fournier R, Serot JM, Achard JM, Messerli FH, Black SE, Fournier A.

Stroke. 2006 Nov;37(11):2666. Epub 2006 Sep 14. No abstract available.

PMID:
16973924
37.

FEVER study: a trial further supporting the concept of a blood pressure-independent stroke protective effect by dihydropyridines.

Modeliard SS, Serot JM, Mansour J, Achard JM, Fournier A.

J Hypertens. 2006 Jun;24(6):1213-5; author reply 1215-6. No abstract available.

PMID:
16685225
38.

Inherited sodium avid states.

Achard JM, Hadchouel J, Faure S, Jeunemaitre X.

Adv Chronic Kidney Dis. 2006 Apr;13(2):118-23. Review.

PMID:
16580612
39.

Does the MOSES trial establish superiority of AT1-receptor blockers over dihydropyridine/calcium antagonists in secondary stroke prevention?

Fournier A, Choukroun G, Modeliar SS, Godefroy O, Achard JM, Wang J, Messerli F.

Stroke. 2006 Feb;37(2):336-7; author reply 338. Epub 2006 Jan 5. No abstract available.

PMID:
16397183
40.

Vasoconstrictive effect of angiotensin IV in isolated rat basilar artery independent of AT1 and AT2 receptors.

Faure S, Javellaud J, Achard JM, Oudart N.

J Vasc Res. 2006;43(1):19-26. Epub 2005 Oct 24.

PMID:
16254439
41.

The renin-angiotensin systems: evolving pharmacological perspectives for cerebroprotection.

Magy L, Vincent F, Faure S, Messerli FH, Wang JG, Achard JM, Fournier A.

Curr Pharm Des. 2005;11(25):3275-91. Review.

PMID:
16250855
42.

Familial hyperkalemic hypertension.

Hadchouel J, Delaloy C, Fauré S, Achard JM, Jeunemaitre X.

J Am Soc Nephrol. 2006 Jan;17(1):208-17. Epub 2005 Oct 12. Review. No abstract available.

43.

VALUE and supremacy of blood pressure control for cardiovascular protection.

Fournier A, Mansour J, Mazouz H, Wang J, Achard JM.

J Hypertens. 2005 Apr;23(4):899-900. No abstract available.

PMID:
15775797
44.

Is the angiotensin II Type 2 receptor cerebroprotective?

Fournier A, Achard JM, Boutitie F, Mazouz H, Mansour J, Oprisiu R, Fernandez L, Messerli F.

Curr Hypertens Rep. 2004 Jun;6(3):182-9. Review.

PMID:
15128469
45.

Cerebroprotection mediated by angiotensin II: a hypothesis supported by recent randomized clinical trials.

Fournier A, Messerli FH, Achard JM, Fernandez L.

J Am Coll Cardiol. 2004 Apr 21;43(8):1343-7. Review.

46.
47.

The CHARM programme.

Mansour J, Peltier M, Oprisiu R, Achard JM, Fournier A.

Lancet. 2003 Nov 15;362(9396):1676-7; author reply 1678-9. No abstract available.

PMID:
14630455
48.

WNK kinases, distal tubular ion handling and hypertension.

Faure S, Delaloy C, Leprivey V, Hadchouel J, Warnock DG, Jeunemaitre X, Achard JM.

Nephrol Dial Transplant. 2003 Dec;18(12):2463-7. Review. No abstract available.

PMID:
14605263
49.

Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate.

Amat S, Bougnoux P, Penault-Llorca F, Fétissof F, Curé H, Kwiatkowski F, Achard JL, Body G, Dauplat J, Chollet P.

Br J Cancer. 2003 May 6;88(9):1339-45.

50.

Familial hyperkalemic hypertension: phenotypic analysis in a large family with the WNK1 deletion mutation.

Achard JM, Warnock DG, Disse-Nicodème S, Fiquet-Kempf B, Corvol P, Fournier A, Jeunemaitre X.

Am J Med. 2003 Apr 15;114(6):495-8. No abstract available.

PMID:
12727582

Supplemental Content

Loading ...
Support Center